$2.00 -0.02 (-0.99%)
11/6/2009 4:00 PM

Array BioPharma, Inc. (ARRY)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.

Current Price $2.00 Mkt Cap $98.62M
Open $2.05 P/E Ratio 0.00
Prev. Close $2.02 Div. (Yield) N/A (N/A)
Daily Range $1.95 - $2.11 Volume 552,164
52-Wk Range $1.68 - $4.68 Avg. Daily Vol. 287,000

ARRY News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to Watchlist

All Members

226 Outperform
6 Underperform
 

All-Star Members

82 Outperform
3 Underperform
 

Wall Street

11 Outperform
0 Underperform
 

Top ARRY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

redwings103149 (29.45)
Submitted September 16, 2009

What a great price to get into this stock. Well little history on arry was that they have had a hugeeee pipeline but have been blessed with some terrible along with a trial 3 data result that did not meet its ends. Away from the bad they have four… More

1 Comment | Reply | Report this Post

cashsage (60.05)
Submitted November 19, 2008

ARRY has a too high valuation compared to its sales potential. It is also loss making.

0 Comments | Reply | Report this Post
ARRY VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about ARRY.

Recs

0
Member Avatar 08PortfolioModel (< 20) Submitted: 10/20/2009 12:18:52 AM : Outperform Start Price: $2.08 ARRY Score: -1.38

Current 2.14, Oct 19 09. Limit 2.09

Report this Post 0 Comments | Reply | Permalink

Recs

1
Member Avatar redwings103149 (29.45) Submitted: 9/15/2009 11:03:37 PM : Outperform Start Price: $2.84 ARRY Score: -31.03

What a great price to get into this stock. Well little history on arry was that they have had a hugeeee pipeline but have been blessed with some terrible along with a trial 3 data result that did not meet its ends. Away from the bad they have four game changers due within the next 6months so spec alone will hype this baby up eventually.

Report this Post 1 Comment | Reply | Permalink

Recs

1
Member Avatar shinier (29.76) Submitted: 9/10/2009 6:31:14 PM : Outperform Start Price: $2.83 ARRY Score: -31.86

Loss-making, but these small pharma's are a gamble. One hit is all it takes.

Report this Post 0 Comments | Reply | Permalink
View All 21 Pitches »

Leaderboard

Find the members with the highest scoring picks in ARRY.

Score Leader

OriginalBarnacle

OriginalBarnacle (67.06) Score: +74.35

The Score Leader is the member with the highest score across all their picks in ARRY.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
cnwarner 39.92 2/6/2007 Underperform 5Y $13.00 -84.62% -21.38% +63.24
anticitradeshort 25.36 4/20/2009 Underperform NS $3.00 -33.33% +26.54% +59.88
1under5out 87.88 7/20/2007 Underperform 5Y $11.69 -82.89% -27.19% +55.70
kidkwak 97.54 7/2/2008 Underperform 1Y $5.08 -60.63% -14.26% +46.36
hescee 29.12 7/1/2008 Underperform 3M $4.81 -58.42% -13.10% +45.32
mm199691 98.57 9/23/2009 Underperform 5Y $2.74 -27.01% -0.42% +26.59
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. 08PortfolioModel < 20 10/21/2009 Outperform 5Y $2.08 -3.84% -2.46% -1.38 1 Comment
Doggity 77.72 10/21/2009 Outperform 5Y $2.09 -4.31% -1.75% -2.55
UncleSachse < 20 10/21/2009 Outperform 1Y $2.09 -4.31% -1.75% -2.55
Charlotte49er < 20 10/21/2009 Outperform 1Y $2.09 -4.31% -1.75% -2.55
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackWMBlair 39.74 2/7/2008 Outperform NS $5.66 -64.66% -15.79% -48.88
TrackMorganJos < 20 12/4/2007 Outperform NS $11.40 -82.46% -23.47% -58.99
TrackCollinsStew 68.32 11/7/2007 Outperform NS $9.95 -79.90% -25.39% -54.51
TrackLehmanBros 76.60 10/9/2007 Outperform NS $10.90 -81.65% -27.87% -53.78
TrackEveillard 89.92 9/30/2007 Outperform NS $11.23 -82.19% -26.44% -55.75 1 Comment
TrackRodmanRen < 20 8/13/2007 Outperform NS $11.06 -81.92% -23.02% -58.90
TrackJPMorgan 78.71 5/23/2007 Outperform NS $13.01 -84.63% -25.95% -58.68
TrackPiperJaff 80.38 1/4/2007 Outperform NS $12.57 -84.09% -19.49% -64.60
TrackOppenheimer 26.63 12/15/2006 Outperform NS $13.02 -84.64% -20.40% -64.24
TrackUnterberg < 20 12/7/2006 Outperform NS $13.20 -77.50% -5.32% -72.18 6/24/2008 @ $2.97
TrackWRHambrecht 59.03 11/9/2006 Outperform NS $11.92 -83.22% -18.21% -65.01
TrackBofASec 93.50 11/2/2006 Outperform NS $9.60 -79.17% -17.33% -61.84
TrackRWBaird 85.02 10/26/2006 Outperform NS $9.52 -69.85% -27.03% -42.82 9/4/2009 @ $2.87

Featured Broker Partners